Mr. Bradley, formerly of Quanterix, ThermoFisher Scientific, and Ahura Scientific brings nearly 15 years of experience commercializing disruptive technologies in life science research from early stage ventures through to market leadership.

Prior to Quanterix, he played a key role in helping Ahura Scientific build its pharmaceutical business and successfully sell the company to ThermoFisher Scientific.

RedShiftBio's AQS3pro is a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market.

It provides direct measurement of previously undetectable changes in protein structural attributes critical to drug product efficacy and quality.

The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS) that enables direct probing of the biophysical structure of proteins. | To read full story, visit https://startuparound.com/read/1580326210.0694587/RedShift-BioAnalytics-Bags-$18M-in-Series-D?ref=audio_experience